Skip to Main Content
American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

American Society of Hematology

Second Look Rapid Response Program

New journals in the Blood portfolio invite you to submit manuscripts previously reviewed at other reputable journals within the scope of the participating journals and receive an initial editorial response within three business days. All submissions to the Second Look program must be within the scope of one of the participating journals: Blood Global Hematology, Blood Immunology & Cellular Therapy, Blood Neoplasia, Blood Red Cells & Iron, and Blood Vessels, Thrombosis & Hemostasis.

Learn more and submit your manuscript.


Blood Neoplasia and Blood VTH Indexed In Pubmed and Scopus

Blood Neoplasia and Blood Vessels, Thrombosis & Hemostasis, members of the Blood Journals portfolio, are now in Pubmed and Scopus, making your research even more discoverable, visible and impactful. With the highest quality and ethical standards of the Blood brand, and recognition of being indexed in Pubmed and Scopus, Blood Neoplasia and Blood VTH are the trusted source and a premier place to publish your research.


Interested in submitting?
Learn why you should publish in the Blood Journals Portfolio.

Blood Journals Portfolio

With an Impact Factor of 23.1,  Blood is one of the most cited peer-reviewed publication in the field of hematology having generated over 165,000 citations in 2024. Since 1946, it has been the premier journal of the American Society of Hematology. Blood provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.
Current Issue  |  Submit  | Learn more

 

Blood Advances*  is ranked among the top most cited hematology journals. It publishes more peer-reviewed hematology research than any other scientific journal worldwide as well as the prestigious ASH Clinical Guidelines. 
Current Issue  |  Submit  | Learn more

Blood Global Hematology* publishes local adaptations of clinical guidelines, epidemiology and public health analyses, and opinions that address hematologic issues. This journal provides a supportive publication experience for authors, particularly those from regions currently underrepresented in medical literature.
Latest Updates  |  Submit  | Learn more

Blood Immunology & Cellular Therapy* focuses on research in basic, translational, and clinical investigations related to cellular and non-cellular immunotherapies for hematological conditions and the underlying immunology.
Latest Updates  |  Submit  | Learn more

Blood Neoplasia* publishes original research on hematologic malignancies and associated disorders, including leukemia, lymphoma, multiple myeloma, Waldenström macroglobulinemia, and much more.  
Current Issue  |  Submit  | Learn more

Blood Red Cells & Iron*  welcomes articles with significant clinical and/or scientific impact on the topics of red blood cells and research relevant to hematologic diseases involving erythroid lineage.
Latest Updates  |  Submit  | Learn more

Blood Vessels, Thrombosis & Hemostasis* publishes research focused on clinical and mechanistic aspects of normal and abnormal hemostasis and vascular function, including acquired bleeding and thrombotic disorders, and much more.
Current Issue  |  Submit  | Learn more

*online only, open access journal

Blood Journals Portfolio – Your Home for Hematology


  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal